These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 38071481)

  • 1. COVID-19 DEATHS AND VACCINATION IN NIGERIA: AN APPRAISAL.
    Okoro EO; Ikoba NA; Giwa AO; Okoro BE; Akpila AS; Salihu MO
    West Afr J Med; 2023 Dec; 40(12 Suppl 1):S40. PubMed ID: 38071481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of booster vaccination in decreasing COVID-19 age-adjusted case fatality rate: Evidence from 32 countries.
    Zhou C; Wheelock ÅM; Zhang C; Ma J; Dong K; Pan J; Li Z; Liang W; Gao J; Xu L
    Front Public Health; 2023; 11():1150095. PubMed ID: 37143970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of COVID-19 on routine immunization in Oyo State, Nigeria: trend analysis of immunization data in the pre- and post-index case period; 2019-2020.
    Babatunde OA; Olatunji MB; Omotajo OR; Ikwunne OI; Babatunde AM; Nihinlola ET; Patrick GF; Dairo DM
    Pan Afr Med J; 2022; 41():54. PubMed ID: 35317483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there an association between COVID-19 mortality and Human development index? The case study of Nigeria and some selected countries.
    Ameye SA; Ojo TO; Adetunji TA; Awoleye MO
    BMC Res Notes; 2022 May; 15(1):186. PubMed ID: 35597995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cohort event monitoring for safety signal detection in adult individuals 18 years and above after immunisation with coronavirus disease 2019 vaccines in Nigeria.
    Osibogun AO; Shuaib FM; Adeyeye CM; Onajole AT; Ejembi CL; Banwat ME; Wright KO; Mohammed A; Adeleye OA; Yahya SJ; Ifeadike CO; Elemuwa UU; Bassey BE; Oluwole EO; Erinoso OA
    Niger Postgrad Med J; 2023; 30(1):18-24. PubMed ID: 36814159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles outbreak response immunization during the COVID-19 pandemic: lessons from Borno State, Nigeria.
    Nomhwange T; Mohammed A; Jean Baptiste AE; Musa A; Yusuf A; Yusuf M; Wagai J; Shettima A; Meleh S; Banda R; Braka F; Luce R; Masresha B
    Pan Afr Med J; 2022; 41():104. PubMed ID: 35432705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the impact of COVID-19 pandemic and response on routine childhood vaccination coverage and equity in Northern Nigeria: a mixed methods study.
    Dadari I; Sharkey A; Hoare I; Izurieta R
    BMJ Open; 2023 Oct; 13(10):e076154. PubMed ID: 37852768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of the first and second waves of COVID-19 pandemic in Djibouti and the vaccination strategy developed for the response.
    Elhakim M; Tourab SB; Salem F; Van De Weerdt R
    BMJ Glob Health; 2022 Jun; 7(Suppl 3):. PubMed ID: 35750346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Describing the Epidemiology of COVID-19 in Nigeria: An Analysis of the First Year of the Pandemic.
    Oleribe O; Olawepo O; Ezechi O; Osita-Oleribe P; Fertleman M; Taylor-Robinson SD
    J Health Care Poor Underserved; 2022; 33(1):33-46. PubMed ID: 35153204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Statistics in the Arab World by the End of October 2022: A Cross-Sectional Study.
    Alrasheedi AA
    Cureus; 2022 Dec; 14(12):e32670. PubMed ID: 36660506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second wave of COVID-19 in Nigeria: Lessons from the first wave.
    Okereke M; Fortune E; Peter AO; Ukor NA; Lucero-Prisno DE
    Int J Health Plann Manage; 2022 Mar; 37(2):650-656. PubMed ID: 34859489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between vaccination rates and excess mortality in Cyprus during the COVID-19 pandemic.
    Lytras T; Athanasiadou M; Demetriou A; Stylianou D; Heraclides A; Kalakouta O
    Vaccine; 2023 May; 41(18):2941-2946. PubMed ID: 37012116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biology of SARS-CoV-2 and epidemiological analysis of COVID-19 pandemic in Nigeria.
    Egbe KA; Lerum NI; Unah UV; Ike AC; Odoh CK; Egbe FA; Ekwom ES
    J Infect Dev Ctries; 2022 Feb; 16(2):252-257. PubMed ID: 35298418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Events Following COVID-19 Vaccination in Rivers State, Nigeria: A Cross-Sectional Study.
    Harry AM; Edet CK; Ekanem NE; Kemdirim CJ; Uduak AE
    Niger Postgrad Med J; 2022; 29(2):89-95. PubMed ID: 35488575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of vaccination delivery around COVID-19 lockdown in Nigeria.
    Sato R
    Hum Vaccin Immunother; 2021 Sep; 17(9):2951-2953. PubMed ID: 33945404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 in Nigeria: account of epidemiological events, response, management, preventions and lessons learned.
    Okoroiwu HU; Ogar CO; Nja GME; Abunimye DA; Ejemot-Nwadiaro RI
    Germs; 2021 Sep; 11(3):391-402. PubMed ID: 34722361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of a social media campaign to promote COVID-19 vaccination in Nigeria.
    Evans WD; Bingenheimer JB; Long M; Ndiaye K; Donati D; Rao NM; Akaba S; Nsofor I; Agha S
    PLoS One; 2023; 18(9):e0290757. PubMed ID: 37713381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Model for National Minimal CFR during Spontaneous Initial Outbreak of Emerging Infectious Disease: Lessons from COVID-19 Pandemic in 214 Nations and Regions.
    Wang X; Fan L; Dai Z; Li L; Wang X
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.